Pivotal bioVenture Partners Investment Advisor LLC
CIK 0001844645
Annualised vol
14.888368%
Beta
0.096527
HHI
1304.010205
Top-10 weight
95.121407%
VaR 95%
1.258352%
VaR 99%
2.830247%
Max drawdown
28.757318%
Matched value
88.94944%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
What the latest 13F shows bought and sold against the quarter before, by share count.
| Ticker | Change | Shares now | Shares before | Share change % | Value now ($) |
|---|---|---|---|---|---|
| PCVX | ADDED | 1,425,470 | 1,372,425 | 3.87% | 82,862,571 |
| ARQT | REDUCED | 1,265,283 | 1,355,892 | -6.68% | 33,175,720 |
| TRVI | ADDED | 1,742,672 | 1,553,726 | 12.16% | 32,500,833 |
| EVMN | UNCHANGED | 1,926,943 | 1,926,943 | 0.0% | 25,609,072 |
| MPLT | REDUCED | 611,446 | 611,447 | 0.0% | 21,914,225 |
| OCS | REDUCED | 1,506,250 | 1,680,283 | -10.36% | 20,891,688 |
| BIOA | UNCHANGED | 653,374 | 653,374 | 0.0% | 16,014,197 |
| IMNM | UNCHANGED | 732,512 | 732,512 | 0.0% | 15,521,929 |
| ZBIO | REDUCED | 490,766 | 591,991 | -17.1% | 12,455,641 |
| AVTX | ADDED | 434,033 | 295,933 | 46.67% | 8,020,930 |
| RLYB | UNCHANGED | 300,579 | 300,579 | 0.0% | 4,809,264 |
| BOLT | CLOSED OUT | 0 | 42,581 | -100.0% | 0 |
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| PCVX | ADDED | VAXCYTE INC | COM | 92243G108 | 82,862,571 | 26.92 | 1425470.0 |
| ARQT | REDUCED | ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 33,175,720 | 10.78 | 1265283.0 |
| TRVI | ADDED | TREVI THERAPEUTICS INC | COM | 89532M101 | 32,500,833 | 10.56 | 1742672.0 |
| - | AVALYN PHARMACEUTICALS INC | COM SHS | 05348Y105 | 31,826,793 | 10.34 | 966792.0 | |
| EVMN | UNCHANGED | EVOMMUNE INC | COM SHS | 30054Y107 | 25,609,072 | 8.32 | 1926943.0 |
| MPLT | REDUCED | MAPLIGHT THERAPEUTICS INC | COM | 56565P103 | 21,914,225 | 7.12 | 611446.0 |
| OCS | REDUCED | OCULIS HOLDING AG | ORDINARY SHARES | H5870P102 | 20,891,688 | 6.79 | 1506250.0 |
| BIOA | UNCHANGED | BIOAGE LABS INC | COM | 09077V100 | 16,014,197 | 5.2 | 653374.0 |
| IMNM | UNCHANGED | IMMUNOME INC | COM | 45257U108 | 15,521,929 | 5.04 | 732512.0 |
| ZBIO | REDUCED | ZENAS BIOPHARMA INC | COM | 98937L105 | 12,455,641 | 4.05 | 490766.0 |
| AVTX | ADDED | AVALO THERAPEUTICS INC | COM NEW | 05338F306 | 8,020,930 | 2.61 | 434033.0 |
| RLYB | UNCHANGED | RALLYBIO CORP | COM | 75120L209 | 4,809,264 | 1.56 | 300579.0 |
| - | RECURSION PHARMACEUTICALS IN | CL A | 75629V104 | 2,185,551 | 0.71 | 595518.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-13 | 307,788,414 | 13 | 14.888368 | 0.096527 | 28.757318 |
| 2026-03-31 | 2026-05-14 | 279,777,960 | 13 | 16.083226 | 0.105461 | 31.273147 |
| 2025-12-31 | 2026-02-13 | 258,658,319 | 12 | 16.218479 | 0.112079 | 29.195527 |
| 2025-09-30 | 2025-11-13 | 172,983,714 | 10 | 18.001117 | 0.126195 | 33.405122 |
| 2025-03-31 | 2025-05-14 | 123,562,016 | 11 | 16.73568 | 0.114514 | 33.197364 |
| 2024-12-31 | 2025-02-13 | 148,065,879 | 11 | 17.051092 | 0.107393 | 38.066108 |